World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
16649
World Ranking
19705
National Ranking
1029

Overview

Carsten Stephan is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these areas, Stephan has contributed extensively to subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research, and Rheumatology.

The scientist's research topics broadly cover prostate cancer treatment and research, prostate cancer diagnosis and treatment, microRNA in disease regulation, cancer-related molecular mechanisms research, urologic and reproductive health conditions, global cancer incidence and screening, as well as circular RNAs in diseases.

Among their recent papers are:

  • PHI density prospectively improves prostate cancer detection, 2021, World Journal of Urology
  • Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality, 2020, Theranostics
  • Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors, 2020, International Journal of Molecular Sciences
  • Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies, 2020, Urologia Internationalis
  • CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC, 2022, Cancers

Stephan frequently collaborates with several co-authors, including Klaus Jung, Glen Kristiansen, Andreas Maxeiner, Michael Lein, and Bernhard Ralla.

Their research is often published in venues such as:

  • International Journal of Molecular Sciences
  • Urologia Internationalis
  • Cancers
  • World Journal of Urology
  • Theranostics

Best Publications

  • Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.

    Annika Schaefer;Monika Jung;Hans-Joachim Mollenkopf;Ina Wagner

  • Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

    W Weichert;A Röske;V Gekeler;T Beckers

  • National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

    Catharine M. Sturgeon;Michael J. Duffy;Ulf Håkan Stenman;Hans Lilja

  • Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples

    Monika Jung;Annika Schaefer;Annika Schaefer;Isabel Steiner;Carsten Kempkensteffen

  • Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

    Falk Ohl;Monika Jung;Chuanliang Xu;Chuanliang Xu;Carsten Stephan

  • Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours

    Florian Jentzmik;Carsten Stephan;Kurt Miller;Mark Schrader

  • MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

    Monika Jung;Hans-Joachim Mollenkopf;Christina Grimm;Ina Wagner

  • Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival

    Glen Kristiansen;Christian Pilarsky;Christoph Wissmann;Simone Kaiser

  • Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning.

    Tobias Franiel;Carsten Stephan;Andreas Erbersdobler;Ekkehart Dietz

  • Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.

    Girish Sardana;Klaus Jung;Carsten Stephan;Eleftherios P. Diamandis

  • Metastamirs: a stepping stone towards improved cancer management.

    Nicole M. A. White;Eman Fatoohi;Maged Metias;Klaus Jung

  • Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort

    Raquel Esgueva;Sven Perner;Christopher J LaFargue;Veit Scheble

  • Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.

    Wilko Weichert;Mathias Schmidt;Volker Gekeler;Carsten Denkert

  • Interchangeability of Measurements of Total and Free Prostate-Specific Antigen in Serum with 5 Frequently Used Assay Combinations: An Update

    Carsten Stephan;Moritz Klaas;Christian Müller;Dietmar Schnorr

  • The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

    Heidrun Gevensleben;Dimo Dietrich;Carsten Golletz;Susanne Steiner

  • ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.

    Glen Kristiansen;Christian Pilarsky;Christoph Wissmann;Carsten Stephan

  • Multicenter Evaluation of an Artificial Neural Network to Increase the Prostate Cancer Detection Rate and Reduce Unnecessary Biopsies

    Carsten Stephan;Henning Cammann;Axel Semjonow;Eleftherios P. Diamandis

  • Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer

    Florian R Fritzsche;Wilko Weichert;Annika Röske;Volker Gekeler

  • CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer

    Glen Kristiansen;Christian Pilarsky;Janja Pervan;Burkhard Stürzebecher

  • GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.

    G Kristiansen;F R Fritzsche;K Wassermann;C Jäger

Frequent Co-Authors

Kurt Miller
Kurt Miller Charité - University Medicine Berlin
Glen Kristiansen
Glen Kristiansen University Hospital Bonn
Manfred Dietel
Manfred Dietel Charité - University Medicine Berlin
Eleftherios P. Diamandis
Eleftherios P. Diamandis Mount Sinai Hospital
George M. Yousef
George M. Yousef University of Toronto
Wilko Weichert
Wilko Weichert Technical University of Munich
Sven Perner
Sven Perner University of Lübeck
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Holger Moch
Holger Moch University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a healthcare career but not ready for medical school, there are several flexible online options to consider. For current registered nurses, cheap rn to bsn programs allow you to earn a bachelor’s degree quickly and at an affordable rate, helping you advance in clinical roles.

Non-nurses who wish to change careers can explore direct entry np programs for non nurses online, providing an accelerated pathway to become a nurse practitioner. Alternatively, online adn programs for non nurses offer an accessible way to become a registered nurse without prior nursing education.

For those interested in healthcare administration and technology, medical billing and coding schools online with financial aid can open doors to high-demand, behind-the-scenes roles—all from home. These online programs make it easier for busy students and working professionals to build rewarding careers in healthcare without the traditional barriers of cost, time, or campus attendance.

Best Scientists Citing Carsten Stephan

Trending Scientists